These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11726328)

  • 1. The irreplaceable image: Acute toxicity in erythroid bone marrow progenitors after antimonial therapy.
    Hernández JA; Navarro JT; Force L
    Haematologica; 2001 Dec; 86(12):1319. PubMed ID: 11726328
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection].
    Santos J; Rivero A; Márquez M
    An Med Interna; 2000 Oct; 17(10):562-3. PubMed ID: 11109659
    [No Abstract]   [Full Text] [Related]  

  • 3. Intradermal treatment of cutaneous leishmaniasis with two antimonial drugs.
    Morsy TA; Essa MH; Aboul Anaan AM; Montasser MF
    J Egypt Soc Parasitol; 1988 Jun; 18(1):341-4. PubMed ID: 2836525
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of visceral leishmaniasis in patients with antimonials: is there a maximal dose?].
    Llorens Soriano P; Vicente Ull R; Paricio Blasco A; Cervera Juan A; Rubio Rodrigo MJ
    An Med Interna; 1999 Nov; 16(11):602. PubMed ID: 10638007
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute pancreatitis due to antimonials in patients with visceral leishmaniasis and HIV infection].
    Cortés E; Ribera E; Cucurull E; de Otero J; Ocaña I; Pahissa A
    Med Clin (Barc); 1995 Apr; 104(15):578-80. PubMed ID: 7769868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful use of miltefosine and sodium stibogluconate, in combination, for the treatment of an HIV-positive patient with visceral leishmaniasis: a case report and brief review of the literature.
    Collini P; Premchand N; Lockwood D; Greig J
    Ann Trop Med Parasitol; 2009 Jul; 103(5):455-9. PubMed ID: 19583915
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimony/interferon-gamma combination in the treatment of visceral leishmaniasis in AIDS.
    Kaplanski G; Buscaylet S; Penot-Ragon C; Durand JM; Soubeyrand J
    AIDS; 1996 Sep; 10(10):1172-4. PubMed ID: 8874638
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute pancreatitis associated with sodium stibogluconate treatment in a patient with human immunodeficiency virus.
    Domingo P; Ferrer S; Kolle L; Muñoz C; Rodriguez P
    Arch Intern Med; 1996 May; 156(9):1029, 1032. PubMed ID: 8624172
    [No Abstract]   [Full Text] [Related]  

  • 9. [Nephrotic syndrome and acute pancreatitis related to glucantime administration].
    Valencia ME; Laguna F; González Lahoz J
    An Med Interna; 2000 Jan; 17(1):54. PubMed ID: 10730416
    [No Abstract]   [Full Text] [Related]  

  • 10. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis: a rare presentation.
    Rijal A; Agrawal S; Agarwalla A; Agrawal A; Rijal S
    Int J Dermatol; 2005 Jun; 44(6):494-6. PubMed ID: 15941439
    [No Abstract]   [Full Text] [Related]  

  • 11. Leishmaniasis (PKDL) as a case of immune reconstitution inflammatory syndrome (IRIS) in HIV-positive patient after initiation of anti-retroviral therapy (ART).
    Tadesse A; Hurissa Z
    Ethiop Med J; 2009 Jan; 47(1):77-9. PubMed ID: 19743785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimony-induced cerebellar ataxia.
    Khalil EA; Ahmed AE; Musa AM; Hussein MH
    Saudi Med J; 2006 Jan; 27(1):90-2. PubMed ID: 16432602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic necrosis following treatment of leishmaniasis with sodium stibogluconate.
    McBride MO; Linney M; Davidson RN; Weber JN
    Clin Infect Dis; 1995 Sep; 21(3):710. PubMed ID: 8527590
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute erythroid toxicity in visceral leishmaniasis: a rare complication of antimonial therapy.
    Sharma S; Malhan P; Pujani M; Rath B
    Indian J Pathol Microbiol; 2008; 51(4):546-7. PubMed ID: 19008592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine.
    Sundar S; Kumar K; Chakravarty J; Agrawal D; Agrawal S; Chhabra A; Singh V
    Trans R Soc Trop Med Hyg; 2006 Jul; 100(7):698-700. PubMed ID: 16325873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal leishmaniasis in an Indian AIDS patient.
    Singh S
    Lancet Infect Dis; 2004 Nov; 4(11):660-1. PubMed ID: 15522675
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous manifestations of visceral leishmaniasis resistant to liposomal amphotericin B in an HIV-positive patient.
    Alsina-Gibert M; López-Lerma I; Martinez-Chamorro E; Herrero-Mateu C
    Arch Dermatol; 2006 Jun; 142(6):787-9. PubMed ID: 16785393
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypoplasia of bone marrow secondary to sodium antimony gluconate.
    Mallick BK
    J Assoc Physicians India; 1990 Apr; 38(4):310-1. PubMed ID: 2167887
    [No Abstract]   [Full Text] [Related]  

  • 19. Sodium stibogluconate.
    Shrestha NK
    Clin Infect Dis; 2006 Nov; 43(10):1371-2. PubMed ID: 17051510
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS).
    Pourahmad M; Hooshmand F; Rahiminejad M
    Int J Dermatol; 2009 Jan; 48(1):59-61. PubMed ID: 19126052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.